Why Your Cardiac Surgery Risk Score Matters More Than You Think
If you or a family member has been told that heart surgery is necessary, there is a good chance a risk score was calculated somewhere along the way. In many European hospitals — and increasingly in centers around the world — that score is the EuroSCORE II.
The problem is that most patients never see the number, never hear it explained, and never understand how it influenced the recommendation they received. That is a gap I want to help close.
As a board-certified cardiovascular and thoracic surgeon, I use risk models every day. They are one piece of the puzzle — not the whole picture — but they matter. A risk score can determine whether you are offered conventional open-heart surgery, a catheter-based procedure, or medical management alone. It can shape which hospital you are referred to and whether your case is presented to a heart team at all.
Understanding the EuroSCORE II calculator gives you a seat at that table. This article will walk you through what the score includes, where it performs well, where it falls short, and how it compares to the STS risk score used predominantly in the United States.
What the EuroSCORE II Calculator Actually Measures
The original EuroSCORE (European System for Cardiac Operative Risk Evaluation) was developed in 1999 using data from nearly 20,000 patients across 128 European surgical centers. It was a breakthrough at the time, but it consistently overestimated mortality in modern patients — sometimes dramatically. By the late 2000s, improvements in surgical technique, anesthesia, and postoperative care had made the original model outdated.
The EuroSCORE II, published in 2012, was a ground-up recalibration using data from over 22,000 patients operated on in 2010. It uses a logistic regression model and incorporates 18 patient-related and procedure-related factors to estimate the probability of in-hospital death. Those factors include:
- Age — risk increases progressively, especially after age 60
- Gender — female sex is associated with modestly higher surgical risk in many studies
- Renal function — measured by creatinine clearance, a strong predictor of outcomes
- Chronic lung disease — graded by severity of treatment required
- Extracardiac arteriopathy — peripheral or cerebrovascular disease
- Previous cardiac surgery — reoperations carry higher technical risk
- Active endocarditis
- Critical preoperative state — patients on ventilators, intra-aortic balloon pumps, or inotropes
- Left ventricular function — ejection fraction categories from good (>50%) to very poor (<20%)
- Recent myocardial infarction
- Pulmonary hypertension — systolic pulmonary artery pressure above 55 mmHg is high risk
- Urgency of surgery — elective, urgent, emergent, or salvage
- Weight of the intervention — isolated CABG is lower risk than combined procedures
- Surgery on the thoracic aorta
The output is a single number: the estimated percentage probability of dying during the hospital stay. A EuroSCORE II of 1.5% means the model predicts roughly a 1-in-67 chance of in-hospital mortality for a patient with that specific combination of risk factors.
If you want to see how risk scoring applies to your own situation, our free cardiac surgery risk calculator can give you a starting point — though no online tool replaces a thorough clinical evaluation.
EuroSCORE vs STS: What Patients Should Know About the Two Major Risk Models
One of the most common questions I receive from patients seeking a second opinion — particularly those who have consulted with surgeons in both the United States and Europe — is how the EuroSCORE vs STS comparison works. Are they interchangeable? Is one better?
The short answer: they are different tools built from different patient populations, and they do not always agree.
Key Differences at a Glance
- Data source: The STS (Society of Thoracic Surgeons) risk model is derived from the STS National Database, which captures outcomes from the vast majority of cardiac surgery programs in the United States and contains millions of patient records. The EuroSCORE II dataset is smaller and drawn from European centers.
- Outcome measured: STS predicts operative mortality (death within 30 days or during the same hospitalization) along with major morbidity endpoints — stroke, renal failure, prolonged ventilation, reoperation, and deep sternal wound infection. EuroSCORE II predicts in-hospital mortality only.
- Procedure specificity: STS has separate, procedure-specific models for isolated CABG, isolated valve surgery, and combined procedures. EuroSCORE II uses a single model with a procedural weight variable — a less granular approach.
- Database updates: The STS models are recalibrated periodically with fresh data. The EuroSCORE II has not been formally recalibrated since its 2010 dataset, which is now 15 years old.
In head-to-head validation studies, the STS model has generally shown better discrimination and calibration for North American patients, while the EuroSCORE II performs reasonably well in European populations but has been shown to overestimate risk in some subgroups — particularly low-risk patients — and underestimate risk in certain high-risk cohorts including those undergoing combined valve-plus-CABG procedures.
A 2018 study published in the European Journal of Cardio-Thoracic Surgery comparing both models in over 5,000 patients found that the STS score had superior calibration across all risk tertiles. Other studies, including a multicenter analysis from the UK, have reported that EuroSCORE II overestimates mortality in isolated CABG by 20-30% in contemporary practice.
None of this means EuroSCORE II is a bad tool. It means it has limitations — just as the STS score does. The important thing is that your surgical team understands those limitations and does not make major decisions based on a single number.
Why This Matters for Treatment Decisions
Here is a practical example. In many European centers, a patient's EuroSCORE II is used to help determine eligibility for transcatheter aortic valve replacement (TAVR) versus conventional surgical aortic valve replacement. European guidelines from the ESC/EACTS use a EuroSCORE II threshold — generally around 4% — as one factor in the decision. The higher the score, the more likely a patient is steered toward a less invasive catheter approach.
But if the score overestimates risk in a particular patient, that patient might be channeled toward TAVR when they could have had an excellent outcome with surgery — potentially getting a more durable valve with a longer track record. The reverse can also happen: a patient with a misleadingly low score might be offered open surgery when their actual risk profile warrants a less invasive option.
This is one of the strongest arguments for obtaining an independent review of your case. If you have been given a surgical recommendation based partly on a risk score, it is worth understanding whether that score accurately reflects your situation — or whether unmeasured factors are being overlooked.
Limitations of the European Cardiac Surgery Risk Score You Should Ask About
Every risk model is only as good as the data behind it and the variables it captures. The European cardiac surgery risk score — whether the original EuroSCORE or EuroSCORE II — has several well-documented blind spots:
- Frailty: EuroSCORE II does not formally account for frailty, which is one of the most powerful predictors of outcomes in elderly patients. A 78-year-old who walks two miles a day and a 78-year-old who is homebound with sarcopenia may receive identical scores.
- Nutritional status and albumin levels: Low serum albumin is a strong independent risk factor for surgical mortality, yet it is not included in the model.
- Liver disease: Outside of critical preoperative states, the model does not capture cirrhosis or hepatic dysfunction, which profoundly affects surgical outcomes.
- Coronary anatomy: The STS model incorporates the number of diseased vessels for CABG risk estimation. EuroSCORE II does not.
- Porcelain aorta or hostile chest: Severe aortic calcification and prior chest radiation are not captured but can dramatically increase surgical complexity.
- Institutional and surgeon volume: No risk calculator accounts for where or by whom the surgery is performed — and the data clearly shows that high-volume centers and experienced surgeons achieve better outcomes.
When I review cases for patients through WhiteGloveMD, these are exactly the kinds of factors I look for. A risk score gives you a starting point. A thorough clinical review — examining your imaging, catheterization data, comorbidities, functional status, and goals — gives you the full picture.
What to Do If You Have Been Quoted a EuroSCORE II Number
If your surgeon has shared a EuroSCORE II result with you, here are the questions I would encourage you to ask:
- "What specific variables went into my score?" — Errors in data entry (wrong creatinine value, incorrect ejection fraction category) can meaningfully change the output.
- "Was my risk also assessed using the STS model?" — If the two models give substantially different estimates, that is an important conversation to have.
- "Does my score account for my overall functional status and frailty?" — If not, ask how those factors are being weighed in the recommendation.
- "How does this score influence the procedure being recommended?" — You have a right to understand whether a threshold score is driving the decision toward one approach over another.
- "What is your center's actual observed mortality for this procedure in patients like me?" — A model predicts population-level risk. Your surgeon's actual outcomes are what matter most.
You do not need a medical degree to ask these questions. You need the confidence that comes from understanding the basics — and you now have that.
Getting an Independent Perspective on Your Risk and Your Options
Risk scores are tools, not verdicts. They help surgical teams stratify patients, benchmark outcomes, and have structured conversations. But they can also be misapplied, taken out of context, or used to justify a recommendation that may not be in your best interest.
Whether your evaluation took place in London, Berlin, Dubai, or New York, the fundamental question is the same: Is this the right procedure, at the right time, by the right team, for me?
That question cannot be answered by a calculator alone. It requires a careful, independent review of your complete clinical picture — your imaging, your hemodynamics, your anatomy, your comorbidities, and your personal goals for recovery and quality of life.
If you have received a cardiac surgery recommendation and want to understand whether your risk assessment tells the full story, a WhiteGloveMD second opinion can provide that clarity. Our process is straightforward: you submit your medical records, and I personally review your case — the same way I would evaluate a patient in my own practice. You receive a detailed, written analysis that includes an independent risk assessment, an evaluation of the proposed surgical plan, and alternative options if they exist. You can learn more about how our review process works.
If you are facing a cardiac surgery decision and have questions about your EuroSCORE II, your risk profile, or whether the recommended procedure is truly the best option for your situation, a WhiteGloveMD second opinion can help you move forward with confidence and clarity.